Product image of Mebucain Orange (Benzoxonium Chloride, Lidocaine Hydrochloride) supplied by GNH India

Mebucain Orange

Active Ingredient:
Benzoxonium Chloride, Lidocaine Hydrochloride
Origin:
EU

Mebucain Orange (Benzoxonium Chloride, Lidocaine Hydrochloride)

Benzoxonium chloride and lidocaine hydrochloride, the active ingredients in Mebucain Orange, are local anesthetics presented as a topical solution for oromucosal use. They provide relief of oral mucosal pain such as mouth ulcers, denture irritation, and sore throat in adults and children.

GNH India supplies Mebucain Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mebucain Orange, a combination of a quaternary ammonium antiseptic and a local anesthetic, is used for conditions affecting the oral mucosa.

  • Mouth ulcers: provides topical pain relief and reduces discomfort.
  • Denture irritation: alleviates soreness and irritation caused by denture wear.
  • Sore throat: soothes throat pain associated with minor infections.
  • Oral mucosal pain: reduces pain from minor injuries or inflammation.

How It Works

  • Benzoxonium chloride acts as a quaternary ammonium antiseptic that disrupts microbial cell membranes, providing antimicrobial activity. Lidocaine hydrochloride blocks voltage‑gated sodium channels on peripheral nerves, inhibiting impulse conduction and producing local anesthesia. The combined actions result in rapid pain relief and a protective antiseptic effect on the oral mucosa.

Side Effects

Mebucain Orange may cause local reactions when applied to the oral mucosa.

Common Side Effects

  • Mild burning sensation at the application site.
  • Transient numbness of the treated area.
  • Altered taste perception.
  • Mild irritation or redness of the mucosa.
  • Temporary increased salivation.

Serious or Rare Side Effects

  • Allergic reaction such as angioedema or anaphylaxis.
  • Severe mucosal ulceration or necrosis.
  • Systemic toxicity from excessive lidocaine absorption.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Persistent dysphagia or airway compromise.

Precautions & Warnings

Before using Mebucain Orange, consider the following safety measures.

  • Pregnancy: consult a healthcare professional before use.
  • Breastfeeding: limited data are available; use only if benefits outweigh potential risks.
  • Age: safety in children under 2 years has not been established.
  • Allergy: avoid if known hypersensitivity to benzoxonium chloride, lidocaine, or related compounds.
  • Concomitant topical anesthetics: do not use with other local anesthetic products to prevent cumulative toxicity.
  • Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mebucain Orange may interact with other medicines; monitor the following.

Major Interactions (Avoid)

  • Concurrent use with other local anesthetics: increased risk of systemic lidocaine toxicity.
  • Use with other quaternary ammonium antiseptics: additive mucosal irritation.
  • Simultaneous systemic lidocaine-containing products: potential for elevated plasma lidocaine levels.

Moderate Interactions (Monitor Closely)

  • Alcohol‑containing mouthwashes: may enhance burning sensation.
  • Antihistamines: could mask early signs of an allergic reaction.
  • CYP450 inhibitors: may reduce lidocaine metabolism, requiring observation for signs of toxicity.

Frequently Asked Questions

Mebucain Orange is an over‑the‑counter combination of benzoxonium chloride and lidocaine hydrochloride formulated as a topical oral solution. It is used to relieve pain and discomfort associated with oral mucosal conditions such as mouth ulcers, denture irritation, and sore throat.

Benzoxonium chloride is a quaternary ammonium antiseptic that disrupts the cell membranes of bacteria and fungi, providing a broad antimicrobial effect on the oral mucosa. This helps reduce the risk of secondary infection while the lidocaine component provides local anesthesia.

The appropriate dose of Mebucain Orange is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the instructions provided on the product label or by their clinician.

Safety data for Mebucain Orange in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Mebucain Orange, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mebucain Orange combines an antiseptic (benzoxonium chloride) with a local anesthetic (lidocaine), offering both antimicrobial protection and pain relief. Compared with single‑agent lidocaine gels, it may provide added infection‑preventive benefits, while its safety profile remains similar to other topical lidocaine products.

Store Mebucain Orange at ambient temperature below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it out of reach of children.

Mebucain Orange is applied directly to the affected oral area using the supplied applicator or a clean fingertip. The patient should allow the solution to remain in contact with the mucosa for the recommended time, usually a few minutes, before swallowing or rinsing.

Serious risks, although rare, include allergic reactions such as angioedema or anaphylaxis, severe mucosal ulceration, and systemic lidocaine toxicity if excessive amounts are absorbed. Any signs of swelling, difficulty breathing, or persistent ulceration should prompt immediate medical attention.

Individuals with a known hypersensitivity to benzoxonium chloride, lidocaine, or any component of the formulation should avoid using Mebucain Orange. It is also not recommended for children under two years of age unless specifically directed by a qualified healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Benzoxonium Chloride, Lidocaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT